P284 Prophylactic medication for the prevention of endoscopic recurrence after ileocolonic resection in Crohn’s disease: a prospective study based on clinical risk stratification

Jeanine Arkenbosch(Erasmus MC), Annemarie C. de Vries(Erasmus MC), Mariëlle Romberg‐Camps(Zuyderland Medisch Centrum), Sander van der Marel(Medisch Centrum Haaglanden), Evelien Beelen(Erasmus MC), Frank Hoentjen(Radboud University Nijmegen), Gürsah Kats‐Ugurlu(University Medical Center Groningen), Carmen S. Horjus(Rijnstate Hospital), Robert West(The Behaviouralist (United Kingdom)), J van der Woude(Erasmus University Rotterdam), Gerard Dijkstra(University Medical Center Groningen), Bindia Jharap(Meander Medisch Centrum), Marjolijn Duijvestein(Amsterdam University Medical Centers), Jeroen Maljaars(Leiden University Medical Center), N E Erler(Erasmus MC), Laurents P S Stassen(Maastricht University Medical Centre), Michail Doukas(Erasmus MC), Sanne Jansen(Reinier de Graaf Hospital), F van Schaik(University Medical Center Utrecht), Nanne K.H. de Boer, Ariadne H.A.G. Ooms(PathoFinder (Netherlands)), Oddeke van Ruler(IJsselland Ziekenhuis)
Journal of Crohn s and Colitis
January 1, 2022
10.1093/ecco-jcc/jjab232.411
Cited by 3

Related Papers

Cassini Observes the Active South Pole of Enceladus
|Science|2006|1.2k
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
|The Lancet|2016|1.2k
Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease
|Gut|2016|800
Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
|Clinical and Translational Gastroenterology|2016|724
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
|Gastroenterology|2015|478